184 related articles for article (PubMed ID: 35388271)
1. Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis.
Zhou L; Ye Z; Zhang E; Chen L; Hou Y; Lin J; Huang F; Yuan Z
Int J Nanomedicine; 2022; 17():1531-1547. PubMed ID: 35388271
[TBL] [Abstract][Full Text] [Related]
2. Dual-Regulated Functionalized Liposome-Nanoparticle Hybrids Loaded with Dexamethasone/TGFβ1-siRNA for Targeted Therapy of Glomerulonephritis.
Fang P; Han L; Liu C; Deng S; Zhang E; Gong P; Ren Y; Gu J; He L; Yuan ZX
ACS Appl Mater Interfaces; 2022 Jan; 14(1):307-323. PubMed ID: 34968038
[TBL] [Abstract][Full Text] [Related]
3. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
4. Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus.
Scindia Y; Deshmukh U; Thimmalapura PR; Bagavant H
Arthritis Rheum; 2008 Dec; 58(12):3884-91. PubMed ID: 19035491
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate.
Li S; Zeng YC; Peng K; Liu C; Zhang ZR; Zhang L
Acta Pharmacol Sin; 2019 Jan; 40(1):143-150. PubMed ID: 29950614
[TBL] [Abstract][Full Text] [Related]
6. Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis.
Yu H; Lin T; Chen W; Cao W; Zhang C; Wang T; Ding M; Zhao S; Wei H; Guo H; Zhao X
Biomaterials; 2019 Oct; 219():119368. PubMed ID: 31349200
[TBL] [Abstract][Full Text] [Related]
7. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
8. PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.
Zou P; Stern ST; Sun D
Pharm Res; 2014 Mar; 31(3):684-93. PubMed ID: 24065591
[TBL] [Abstract][Full Text] [Related]
9. Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium.
Asgeirsdóttir SA; Kamps JA; Bakker HI; Zwiers PJ; Heeringa P; van der Weide K; van Goor H; Petersen AH; Morselt H; Moorlag HE; Steenbergen E; Kallenberg CG; Molema G
Mol Pharmacol; 2007 Jul; 72(1):121-31. PubMed ID: 17452496
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury.
Hou M; Wu X; Zhao Z; Deng Q; Chen Y; Yin L
Acta Biomater; 2022 Apr; 143():344-355. PubMed ID: 35189380
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
12. Construction of PLGA nanoparticles modified with RWrNM and DLPC and their application in acute rhinosinusitis.
Tao W; Xie P; Huang C; Wang Y; Huang Y; Yin Z
Drug Deliv Transl Res; 2024 Apr; 14(4):1063-1076. PubMed ID: 37966678
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
14. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
16. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
17. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
18. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes.
Asgeirsdóttir SA; Zwiers PJ; Morselt HW; Moorlag HE; Bakker HI; Heeringa P; Kok JW; Kallenberg CG; Molema G; Kamps JA
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F554-61. PubMed ID: 18160627
[TBL] [Abstract][Full Text] [Related]
19. Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis.
Morimoto K; Kondo M; Kawahara K; Ushijima H; Tomino Y; Miyajima M; Kimura J
Pharm Res; 2007 May; 24(5):946-54. PubMed ID: 17372685
[TBL] [Abstract][Full Text] [Related]
20. Magnetic core-shell nanoparticles for drug delivery by nebulization.
Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
